rs16950650
From SNPedia
Orientation | plus |
Stabilized | plus |
Geno | Mag | Summary |
---|---|---|
(C;C) | 0 |
Make rs16950650(C;T) |
Make rs16950650(T;T) |
Reference | GRCh38 38.1/141 |
Chromosome | 13 |
Position | 95123178 |
Gene | ABCC4 |
is a | snp |
is | mentioned by |
dbSNP | rs16950650 |
dbSNP (classic) | rs16950650 |
ClinGen | rs16950650 |
ebi | rs16950650 |
HLI | rs16950650 |
Exac | rs16950650 |
Gnomad | rs16950650 |
Varsome | rs16950650 |
LitVar | rs16950650 |
Map | rs16950650 |
PheGenI | rs16950650 |
Biobank | rs16950650 |
1000 genomes | rs16950650 |
hgdp | rs16950650 |
ensembl | rs16950650 |
geneview | rs16950650 |
scholar | rs16950650 |
rs16950650 | |
pharmgkb | rs16950650 |
gwascentral | rs16950650 |
openSNP | rs16950650 |
23andMe | rs16950650 |
SNPshot | rs16950650 |
SNPdbe | rs16950650 |
MSV3d | rs16950650 |
GWAS Ctlg | rs16950650 |
GMAF | 0.03719 |
Max Magnitude | 0 |
? | (C;C) (C;T) (T;T) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 23478653] |
Trait | Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer |
Title | A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy. |
Risk Allele | T |
P-val | 2E-7 |
Odds Ratio | 30.20 [8.4-109.0] |